Literature DB >> 2283996

The importance of renal ammonia metabolism to whole body acid-base balance: a reanalysis of the pathophysiology of renal tubular acidosis.

I Kurtz1, P D Dass, S Cramer.   

Abstract

Traditionally, the renal collecting duct has been assigned the dual role of (1) secreting protons derived from dietary metabolism to form luminal NH4+ and titratable acid and (2) generating new HCO3-. This view has recently been challenged. According to current concepts, whole body proton balance is maintained predominantly by the lungs which excrete protons derived from dietary metabolism as the acid anhydride CO2. In the process of excreting CO2, HCO3- is also lost from the body. It is the function of the kidney to generate new HCO3- to replenish this loss. The major site of new HCO3- generation is the proximal tubule rather than the collecting duct. New HCO3- is generated predominantly via the metabolism of organic anions, i.e. alpha-ketoglutarate, citrate, lactate, fatty acids. In the process of generating alpha-ketoglutarate from glutamine, NH4+ is formed. Under normal acid-base conditions, 50% of the NH4+ produced is excreted in the urine, and the remaining 50% is delivered to the renal veins. NH4+ delivered to the renal veins consumes HCO3- during ureagenesis. In the discussion which follows, these new concepts are reviewed and applied to an analysis of the pathophysiology of renal tubular acidosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283996

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  9 in total

Review 1.  Molecular mechanisms and regulation of urinary acidification.

Authors:  Ira Kurtz
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 2.  Renal Tubular Acidosis: H+/Base and Ammonia Transport Abnormalities and Clinical Syndromes.

Authors:  Ira Kurtz
Journal:  Adv Chronic Kidney Dis       Date:  2018-07       Impact factor: 3.620

3.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

4.  Stone composition as a function of age and sex.

Authors:  John C Lieske; Andrew D Rule; Amy E Krambeck; James C Williams; Eric J Bergstralh; Ramila A Mehta; Thomas P Moyer
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 8.237

5.  Intercalated cell-specific Rh B glycoprotein deletion diminishes renal ammonia excretion response to hypokalemia.

Authors:  Jesse M Bishop; Hyun-Wook Lee; Mary E Handlogten; Ki-Hwan Han; Jill W Verlander; I David Weiner
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

6.  NaHCO3 Dilates Mouse Afferent Arteriole Via Na+/HCO3- Cotransporters NBCs.

Authors:  Shan Jiang; Ximing Wang; Jin Wei; Gensheng Zhang; Jie Zhang; Peng Xie; Lan Xu; Lei Wang; Liang Zhao; Lingli Li; Christopher S Wilcox; Jianghua Chen; En Yin Lai; Ruisheng Liu
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

7.  Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China.

Authors:  Shike Zhang; Yapeng Huang; Weizhou Wu; Zhican He; LiLi Ou; Hans-Göran Tiselius; Guohua Zeng; Wenqi Wu
Journal:  World J Urol       Date:  2021-03-29       Impact factor: 4.226

Review 8.  Clinical review: Renal tubular acidosis--a physicochemical approach.

Authors:  Troels Ring; Sebastian Frische; Søren Nielsen
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

9.  An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance.

Authors:  Shengnan Xu; Kathryn E Ware; Yuantong Ding; So Young Kim; Maya U Sheth; Sneha Rao; Wesley Chan; Andrew J Armstrong; William C Eward; Mohit Kumar Jolly; Jason A Somarelli
Journal:  J Clin Med       Date:  2019-02-07       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.